Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific nerve condition called CIDP (typical or possible typical type), based on recognised 2021 medical guidelines
- People who are 18 years of age or older
- People who are able to use a smartwatch, as assessed by the trial doctor
- People who have recently switched from an intravenous immunoglobulin treatment (given through a drip) to a under-the-skin immunoglobulin treatment within the past 6 months, or who are planning to make that switch during the study recruitment period
- People whose immunoglobulin treatment before the switch was confirmed by their doctor to be stable
Who may not be able to join:
- People under 18 years of age
- People who are unable to operate a smartwatch or smartphone
- People who are currently pregnant or breastfeeding
- People whose CIDP diagnosis falls into a variant category according to the 2021 medical guidelines (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marc G Pawlitzki, PD Dr. med., Department of Neurology, Heinrich-Heine University, and University Hospital Duesseldorf, Germany
Phone: +49 02118117887
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Inflammatory Rasch-built Overall Disability Scale (I-RODS); Change in Inflammatory Neuropathy Cause and Treatment (INCAT) disability score; Longitudinal development of activity parameter: step count; Longitudinal development of activity parameter: duration of moderate activity (seconds) defined by Withings
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.